View in EDS HTML Full Text PDF Full Text

Author Correction: Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models.

Saved in:
Bibliographic Details
Title: Author Correction: Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models.
Authors: Pierini S; Carisma Therapeutics Inc, Philadelphia, PA, USA., Gabbasov R; Carisma Therapeutics Inc, Philadelphia, PA, USA., Oliveira-Nunes MC; Carisma Therapeutics Inc, Philadelphia, PA, USA., Qureshi R; Carisma Therapeutics Inc, Philadelphia, PA, USA., Worth A; Carisma Therapeutics Inc, Philadelphia, PA, USA., Huang S; Carisma Therapeutics Inc, Philadelphia, PA, USA., Nagar K; Carisma Therapeutics Inc, Philadelphia, PA, USA., Griffin C; Carisma Therapeutics Inc, Philadelphia, PA, USA., Lian L; Carisma Therapeutics Inc, Philadelphia, PA, USA., Yashiro-Ohtani Y; Carisma Therapeutics Inc, Philadelphia, PA, USA., Ross K; Carisma Therapeutics Inc, Philadelphia, PA, USA., Sloas C; Carisma Therapeutics Inc, Philadelphia, PA, USA., Ball M; Carisma Therapeutics Inc, Philadelphia, PA, USA., Schott B; Carisma Therapeutics Inc, Philadelphia, PA, USA., Sonawane P; Carisma Therapeutics Inc, Philadelphia, PA, USA., Cornell L; Carisma Therapeutics Inc, Philadelphia, PA, USA., Blumenthal D; Carisma Therapeutics Inc, Philadelphia, PA, USA., Chhum S; Carisma Therapeutics Inc, Philadelphia, PA, USA., Minutolo N; Carisma Therapeutics Inc, Philadelphia, PA, USA., Ciccaglione K; Carisma Therapeutics Inc, Philadelphia, PA, USA., Shaw L; Carisma Therapeutics Inc, Philadelphia, PA, USA., Zentner I; Carisma Therapeutics Inc, Philadelphia, PA, USA., Levitsky H; Carisma Therapeutics Inc, Philadelphia, PA, USA., Shestova O; Center for Cellular Immunotherapies, Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Gill S; Center for Cellular Immunotherapies, Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Varghese B; Carisma Therapeutics Inc, Philadelphia, PA, USA., Cushing D; Carisma Therapeutics Inc, Philadelphia, PA, USA., Ceeraz DeLong S; Carisma Therapeutics Inc, Philadelphia, PA, USA., Abramson S; Carisma Therapeutics Inc, Philadelphia, PA, USA., Condamine T; Carisma Therapeutics Inc, Philadelphia, PA, USA., Klichinsky M; Carisma Therapeutics Inc, Philadelphia, PA, USA. michael.klichinsky@carismatx.com.
Source: Nature communications [Nat Commun] 2025 Mar 19; Vol. 16 (1), pp. 2692. Date of Electronic Publication: 2025 Mar 19.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40108132
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pierini+S%22">Pierini S</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Gabbasov+R%22">Gabbasov R</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Oliveira-Nunes+MC%22">Oliveira-Nunes MC</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Qureshi+R%22">Qureshi R</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Worth+A%22">Worth A</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Huang+S%22">Huang S</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Nagar+K%22">Nagar K</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Griffin+C%22">Griffin C</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Lian+L%22">Lian L</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Yashiro-Ohtani+Y%22">Yashiro-Ohtani Y</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Ross+K%22">Ross K</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Sloas+C%22">Sloas C</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Ball+M%22">Ball M</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Schott+B%22">Schott B</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Sonawane+P%22">Sonawane P</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Cornell+L%22">Cornell L</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Blumenthal+D%22">Blumenthal D</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Chhum+S%22">Chhum S</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Minutolo+N%22">Minutolo N</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Ciccaglione+K%22">Ciccaglione K</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Shaw+L%22">Shaw L</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Zentner+I%22">Zentner I</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Levitsky+H%22">Levitsky H</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Shestova+O%22">Shestova O</searchLink>; Center for Cellular Immunotherapies, Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Gill+S%22">Gill S</searchLink>; Center for Cellular Immunotherapies, Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Varghese+B%22">Varghese B</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Cushing+D%22">Cushing D</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Ceeraz+DeLong+S%22">Ceeraz DeLong S</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Abramson+S%22">Abramson S</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Condamine+T%22">Condamine T</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Klichinsky+M%22">Klichinsky M</searchLink>; Carisma Therapeutics Inc, Philadelphia, PA, USA. michael.klichinsky@carismatx.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2025 Mar 19; Vol. 16 (1), pp. 2692. <i>Date of Electronic Publication: </i>2025 Mar 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40108132
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-025-57496-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2692
    Titles:
      – TitleFull: Author Correction: Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pierini S
      – PersonEntity:
          Name:
            NameFull: Gabbasov R
      – PersonEntity:
          Name:
            NameFull: Oliveira-Nunes MC
      – PersonEntity:
          Name:
            NameFull: Qureshi R
      – PersonEntity:
          Name:
            NameFull: Worth A
      – PersonEntity:
          Name:
            NameFull: Huang S
      – PersonEntity:
          Name:
            NameFull: Nagar K
      – PersonEntity:
          Name:
            NameFull: Griffin C
      – PersonEntity:
          Name:
            NameFull: Lian L
      – PersonEntity:
          Name:
            NameFull: Yashiro-Ohtani Y
      – PersonEntity:
          Name:
            NameFull: Ross K
      – PersonEntity:
          Name:
            NameFull: Sloas C
      – PersonEntity:
          Name:
            NameFull: Ball M
      – PersonEntity:
          Name:
            NameFull: Schott B
      – PersonEntity:
          Name:
            NameFull: Sonawane P
      – PersonEntity:
          Name:
            NameFull: Cornell L
      – PersonEntity:
          Name:
            NameFull: Blumenthal D
      – PersonEntity:
          Name:
            NameFull: Chhum S
      – PersonEntity:
          Name:
            NameFull: Minutolo N
      – PersonEntity:
          Name:
            NameFull: Ciccaglione K
      – PersonEntity:
          Name:
            NameFull: Shaw L
      – PersonEntity:
          Name:
            NameFull: Zentner I
      – PersonEntity:
          Name:
            NameFull: Levitsky H
      – PersonEntity:
          Name:
            NameFull: Shestova O
      – PersonEntity:
          Name:
            NameFull: Gill S
      – PersonEntity:
          Name:
            NameFull: Varghese B
      – PersonEntity:
          Name:
            NameFull: Cushing D
      – PersonEntity:
          Name:
            NameFull: Ceeraz DeLong S
      – PersonEntity:
          Name:
            NameFull: Abramson S
      – PersonEntity:
          Name:
            NameFull: Condamine T
      – PersonEntity:
          Name:
            NameFull: Klichinsky M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 03
              Text: 2025 Mar 19
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1